1988-2015
Following the death of Hubertus Liebrecht (1991), the owning family made some fundamental decisions regarding the company’s alignment. Learn more here.
Search
Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
Global Code of Conduct
Our Code of Conduct demonstrates for each and every one that integrity is “part of our DNA”. Click here to learn more about our Code of Conduct.
Solidarity with Ukraine
Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term. Click here to learn more.
Science against COVID-19 fake news and misinformation
As there is no evidence that animals can transmit COVID-19, the livestock community highlights information to join the battle against false claims.
1885-1948
In 1885, Albert Boehringer purchased a small tartar factory in the Rhine-Hessian village of Nieder-Ingelheim. Click here to learn more about our history.
Lyon
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Lyon site.
Stroke, Don’t Stay at Home
During COVID-19, there was a decrease in stroke hospital admissions. Learn why it is crucial that patients can still access urgent care at this time.
Watch out: the tick season is there!
From a Southern tick species spreading throughout Europe to the fact American pop singer Justin Bieber is battling Lyme disease, ticks are in the news.
COVID-19 Boehringer Ingelheim Singapore charity donations
Find out how Boehringer Ingelheim Singapore is offering support for healthcare workers and vulnerable communities. Click here to learn more.
Ethical Business Practices
Suppliers shall conduct their business in an ethical manner and act with integrity. Click here to read the supplier code of conduct and learn more.
From Idea to Drug
Development of a new drug starts with the hunt for effective compounds and finishes with the approval of the drug. Click here to learn more.
Accountability, Agility, Intrapreneurship
At Boehringer Ingelheim we work together with accountability, agility, and intrapreneurship. Click here to read about what this means for us here.
COVID-19 USA Double the Impact in the Fight Against COVID-19
Employees can double their impact through the BI Cares Matching Gifts Program. Click here to learn and find out more information about this.
Coronavirus in pets and humans: learn the differences
Coronavirus in pets and humans: learn the differences. To date, there is no evidence that dogs and cats can be infected or transmit COVID-19.
COVID-19 Mexico - The value of teamwork
During the pandemic, Fabiola Villegas, contributed with creativity and ingenuity from her region in Uruapan, Michoacán, Mexico. Click here to learn more.
We create Value through Innovation for our customers
We create value through innovation for our customers. Discover how we live our Leitbild. Click here to find out more and to access related articles.
Harold Heart and Dorothy Diabetes
People with type 2 diabetes are up to four times more likely to develop cardiovascular disease than people without diabetes. Click here to learn more.
Ingelheim
The company headquarters of Boehringer Ingelheim are located in Ingelheim, Germany. Click here to find out and learn more about our headquarters.
Introducing Karl and Klara Kidney
Kidney disease and type 2 diabetes are closely linked, and share many of the same risk factors and pathological pathways. Click here to find out more.
We are independent, family-owned
At Boehringer Ingelheim we are independent, family-owned and intend to remain so. Click here to discover how we live our Leitbild and learn more.
History of Cats
Since the beginning of human civilisation, cats have been companions to people. Click here to learn more about the history of cats with humans.
COVID-19 Spain pulse oximeters donation
Boehringer Ingelheim Spain has contributed to the COVIDALARM project by financing the purchase of 200 intelligent pulse oximeters. Learn more here.
Our Ambition 2025
Boehringer Ingelheim’s commitment to serve humankind can be met if we are the preferred partner and admired competitor in three areas. Learn more here.
Patient Documentary
People with type 2 diabetes are two to four times more likely to develop heart disease compared with people without diabetes